Difference between revisions of "Main Page/Remote Monitoring of Implantable Cardioverter-Defibrillators : A Systematic Review and Meta-Analysis of Clinical Outcomes"
From Clinfowiki
Anita Bandri (Talk | contribs) |
Anita Bandri (Talk | contribs) |
||
| Line 1: | Line 1: | ||
| − | This is a systematic review of the randomized controlled trials comparing Remote Monitoring (RM) with In-office (IO) follow-up of implantable cardioverter-defibrillators (ICD). | + | This article is a systematic review of the randomized controlled trials comparing Remote Monitoring (RM) with In-office (IO) follow-up of implantable cardioverter-defibrillators (ICD).<ref name="ICD">N. Parthiban, A. Esterman, R. Mahajan, D. J. Twomey, R. K. Pathak, D. H. Lau, K. C. Roberts-Thomson, G. D. Young, P. Sanders, A. N. Ganesan. Remote Monitoring of Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Clinical Outcomes. J Am Coll Cardiol. 2015 Jun 23;65(24):2591-600. doi: 10.1016/j.jacc.2015.04.029. Epub 2015 May 13.http://www.sciencedirect.com.ezproxyhost.library.tmc.edu/science/article/pii/S0735109715020306</ref> |
==Background== | ==Background== | ||
| − | Implantable cardioverter-defibrillators (ICD) have become the standard of care therapy for primary and secondary prevention of sudden cardiac death. | + | Implantable cardioverter-defibrillators (ICD) have become the standard of care therapy for primary and secondary prevention of sudden cardiac death. Remote monitoring (RM) of ICD devices has been proposed as an alternative strategy to reduce the need for routine device follow-up visits while providing continuous surveillance and immediate problem notification. |
| + | |||
| + | |||
| + | |||
| + | |||
| + | ==References== | ||
| + | <references/> | ||
Revision as of 17:25, 6 November 2015
This article is a systematic review of the randomized controlled trials comparing Remote Monitoring (RM) with In-office (IO) follow-up of implantable cardioverter-defibrillators (ICD).[1]
Background
Implantable cardioverter-defibrillators (ICD) have become the standard of care therapy for primary and secondary prevention of sudden cardiac death. Remote monitoring (RM) of ICD devices has been proposed as an alternative strategy to reduce the need for routine device follow-up visits while providing continuous surveillance and immediate problem notification.
References
- ↑ N. Parthiban, A. Esterman, R. Mahajan, D. J. Twomey, R. K. Pathak, D. H. Lau, K. C. Roberts-Thomson, G. D. Young, P. Sanders, A. N. Ganesan. Remote Monitoring of Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Clinical Outcomes. J Am Coll Cardiol. 2015 Jun 23;65(24):2591-600. doi: 10.1016/j.jacc.2015.04.029. Epub 2015 May 13.http://www.sciencedirect.com.ezproxyhost.library.tmc.edu/science/article/pii/S0735109715020306
